Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus

被引：0
|
作者：
FF Falcini
CS Capannini
MG Martini
LTF La Torre
VA Vitale
NF Nacci
MCM Matucci Cerinic
CR Cimaz
ZF Zulian
机构：
[1] University of Florence,Department of Biomedicine, Division of Rheumatology, Transition Unit
[2] University of Padua,Department of Paediatrics, Rheumatology Unit
[3] University of Messina,Department of Paediatrics, Rheumatology Unit
[4] University of Florence,A. Meyer Children's Hospital, Rheumatology Unit
来源：
Pediatric Rheumatology | / 6卷 / Suppl 1期
关键词：
Steroid; Systemic Lupus Erythematosus; Renal Disease; Blood Count; Treatment Duration;
D O I：
10.1186/1546-0096-6-S1-P234
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Experience with Mycophenolate Mofetil as Maintenance Therapy in five Pediatric Patients with Severe Systemic Lupus Erythematosus
    Dittrich, K.
    Ross, S.
    Benz, K.
    Amann, K.
    Doetsch, J.
    KLINISCHE PADIATRIE, 2009, 221 (07): : 425 - 429
  • [32] Listeria brain abscesses during administration of mycophenolate mofetil for systemic lupus erythematosus: a case report
    Giulia Perini
    Roberta Pravettoni
    Elisabetta Farina
    Giulia Grande
    Patrizia Contri
    Claudio Mariani
    Neurological Sciences, 2015, 36 : 1019 - 1020
  • [33] Listeria brain abscesses during administration of mycophenolate mofetil for systemic lupus erythematosus: a case report
    Perini, Giulia
    Pravettoni, Roberta
    Farina, Elisabetta
    Grande, Giulia
    Contri, Patrizia
    Mariani, Claudio
    NEUROLOGICAL SCIENCES, 2015, 36 (06) : 1019 - 1020
  • [34] Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
    Till Fassbinder
    Ute Saunders
    Eva Mickholz
    Elisabeth Jung
    Heidemarie Becker
    Bernhard Schlüter
    Annett Marita Jacobi
    Arthritis Research & Therapy, 17
  • [35] Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosus compared with adult onset systemic lupus erythematosus
    Pisoni, Cecilia N.
    Andres Munoz, Sebastian
    Carrizo, Carolina
    Cosatti, Micaela
    Alvarez, Analia
    Dubinsky, Diana
    Bresan, Eleonora
    Russo, Ricardo
    Borgia, Ezequiel
    Garcia, Mercedes
    Sansinanea, Pierina
    Cristina Basta, Maria
    Agustina D'Amico, Maria
    Carlos Barreira, Juan
    Lancioni, Eliana
    Soriano, Enrique
    de Cunto, Carmen
    Beron, Ana
    Eimon, Alicia
    REUMATOLOGIA CLINICA, 2015, 11 (02): : 73 - 77
  • [36] Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options
    Smith, Eve Mary Dorothy
    Lythgoe, Hanna
    Midgley, Angela
    Beresford, Michael William
    Hedrich, Christian Michael
    CLINICAL IMMUNOLOGY, 2019, 209
  • [37] Endocrine and metabolic comorbidities in juvenile-onset systemic lupus erythematosus
    Park, Su Jin
    Ahn, Moon Bae
    Jeong, Dae Chul
    FRONTIERS IN MEDICINE, 2025, 12
  • [38] Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature
    Balci, M. A.
    Pamuk, G. E.
    Unlu, E.
    Usta, U.
    Pamuk, O. N.
    LUPUS, 2017, 26 (11) : 1224 - 1227
  • [39] CAN WE IDENTIFY WHO BENEFITS FROM MYCOPHENOLATE MOFETIL IN SYSTEMIC LUPUS ERYTHEMATOSUS? A SYSTEMATIC REVIEW
    Mendoza Pinto, C.
    Pirone, C.
    Parker, B.
    Bruce, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S115 - S115
  • [40] Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study
    Ayano, Masahiro
    Kimoto, Yasutaka
    Mitoma, Hiroki
    Akahoshi, Mitsuteru
    Ono, Nobuyuki
    Arinobu, Yojiro
    Akashi, Koichi
    Horiuchi, Takahiko
    Niiro, Hiroaki
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
12345